Status: Recruiting
The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit.
The goal of this clinical trial is to evaluate the performance of a photorefraction screener in terms of sensibility, sensitivity and accuracy on children aged 3 to 8 y.o. The main objectives of the study are: * Evaluate the performances of the device in comparison with the gold standard, i.e. a tabletop refractometer. * Assess the agreement of the measures obtained with the device with those obtained with the gold standard.
Participants needed: 315
Trial details
Age: 3-8Biological sex: AllType: InterventionalSponsor: Essilor InternationalUpdated: Apr 29, 2025Locations: 2
Eligibility criteria
Aged between 3-8 years when included in the study [+5]
Under myopia control solution that may have an impact on refractive error (such... [+6]